Literature DB >> 1700701

Characterization of a major development-regulated serum thyroxine-binding globulin in the euthyroid mouse.

R Vranckx1, L Savu, M Maya, E A Nunez.   

Abstract

We confirm our finding of a major development-regulated thyroxine-binding globulin (TBG) in the serum of the euthyroid mouse and investigate a number of its binding, structural and regulatory properties. Between 16 days foetal and 60 days postnatal life, the thyroxine (T4)- and tri-iodothyronine (T3)-binding activities of the sera show a striking ontogenic pattern: the binding is 2-3 times higher in foetuses than in mothers, then further increases after birth, reaching between 3 and 5 days maximum values which are 7-8 times higher than the adult ones. This pattern is not correlated with the ontogenesis of the acknowledged specific (transthyretin, TTR) and non-specific (albumin, alpha 1-foetoprotein) thyroid-hormone carriers of the mouse sera. PAGE studies demonstrate that the protein responsible for the elevated binding of the perinatal period is an alpha 1-globulin, with a migration similar to that of human and rat TBGs. Scatchard analysis is consistent with the notions that the T4-binding sites of TBG have high association constants, about two orders of magnitude above the T4 sites of TTR (10(9) M-1 as against 10(7) M-1) and low capacities (37 and 4 nmol/g of serum proteins in pups and adults respectively). Isoelectric focusing (i.e.f.) demonstrates that mouse TBG is a microheterogeneous protein separable, as a function of the pH gradient, in up to 10-12 isoforms, Marked shifts of the relative abundance of isoforms in the course of development are evidenced. The modulation of the TBG binding activity by non-esterified fatty acids (NEFA) and the control of its synthesis by the thyroid status are also reported. Mono- and poly-unsaturated NEFAs are strong inhibitors of the TBG, although they affect TTR less readily. On the other hand, the biosynthesis and/or secretion of TBG, but not of TTR, is under thyroid-hormone control, experimental hypothyroidism inducing a marked increase of the serum TBG. The TBG of mouse behaves as a highly significant parameter of development, pointing to a likely important function of the protein in the process of maturation. Our finding of major TBGs in both euthyroid rats and mice suggests that TBG is more widely spread than was thought until now, but difficult to detect in certain species outside definite maturation stages.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700701      PMCID: PMC1149564          DOI: 10.1042/bj2710373

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

4.  A thyroxine binding globulin (TBG)-like protein in the sera of developing and adult rats.

Authors:  L Savu; R Vranckx; M Maya; E A Nunez
Journal:  Biochem Biophys Res Commun       Date:  1987-11-13       Impact factor: 3.575

5.  Thyroxine-binding globulin and thyroxine-binding prealbumin in hypothyroid and hyperthyroid developing rats.

Authors:  L Savu; R Vranckx; M Maya; D Gripois; M F Blouquit; E A Nunez
Journal:  Biochim Biophys Acta       Date:  1989-09-15

6.  [A thyroxine-binding globulin of major biological significance in the serum of mice: demonstration and ontogenesis].

Authors:  L Savu; R Vranckx; M Maya; E A Nunez
Journal:  C R Acad Sci III       Date:  1989

7.  Differential binding of thyroxine and triiodothyronine to acidic isoforms of thyroid hormone binding globulin in human serum.

Authors:  T Terasaki; W M Pardridge
Journal:  Biochemistry       Date:  1988-05-17       Impact factor: 3.162

8.  Abnormal free fatty acids and cortisol concentrations in the serum of AIDS patients.

Authors:  N Christeff; C Michon; G Goertz; J Hassid; S Matheron; P M Girard; J P Coulaud; E A Nunez
Journal:  Eur J Cancer Clin Oncol       Date:  1988-07

9.  Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroid illnesses.

Authors:  I J Chopra; G N Teco; J F Mead; T S Huang; A Beredo; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1985-05       Impact factor: 5.958

10.  Binding activities of thyroxine binding globulin versus thyroxine binding prealbumin in rat sera: differential modulation by thyroid hormone ligands, oleic acid and pharmacological drugs.

Authors:  L Savu; R Vranckx; M Maya; E A Nunez
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

View more
  16 in total

1.  An association study between the transthyretin (TTR) gene and mental retardation.

Authors:  Jun Li; Jian-Jun Gao; Fu-Chang Zhang; Qing-He Xing; Fang-Li Dang; Xiao-Cai Gao; Shi-Wei Duan; Zi-Jian Zheng; Xue-Qing Qian; Wei Qin; Xing-Wang Li; Yan-Feng Han; Jing Li; Guo-Yin Feng; D St Clair; Lin He
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-12-19       Impact factor: 5.270

2.  Binding of perlecan to transthyretin in vitro.

Authors:  S Smeland; S O Kolset; M Lyon; K R Norum; R Blomhoff
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 3.  Studies on thyroxine-binding globulin.

Authors:  L Bartalena
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

4.  Effects of cigarette smoke exposure during suckling on food intake, fat mass, hormones, and biochemical profile of young and adult female rats.

Authors:  Patricia Cristina Lisboa; Patricia Novaes Soares; Thamara Cherem Peixoto; Janaine Cavalcanti Carvalho; Camila Calvino; Vanessa Silva Tavares Rodrigues; Dayse Nascimento Bernardino; Viviane Younes-Rapozo; Alex Christian Manhães; Elaine de Oliveira; Egberto Gaspar de Moura
Journal:  Endocrine       Date:  2017-05-19       Impact factor: 3.633

Review 5.  A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer.

Authors:  John R Foster; Helen Tinwell; Stephanie Melching-Kollmuss
Journal:  Arch Toxicol       Date:  2021-01-05       Impact factor: 5.153

6.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

7.  Structural and functional microheterogeneity of rat thyroxine-binding globulin during ontogenesis.

Authors:  M Rouaze-Romet; R Vranckx; L Savu; E A Nunez
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

8.  Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst.

Authors:  S A Duncan; K Manova; W S Chen; P Hoodless; D C Weinstein; R F Bachvarova; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone.

Authors:  V Episkopou; S Maeda; S Nishiguchi; K Shimada; G A Gaitanaris; M E Gottesman; E J Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 10.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement.

Authors:  Evanthia Diamanti-Kandarakis; Jean-Pierre Bourguignon; Linda C Giudice; Russ Hauser; Gail S Prins; Ana M Soto; R Thomas Zoeller; Andrea C Gore
Journal:  Endocr Rev       Date:  2009-06       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.